Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.

Kramer K, Gerald W, LeSauteur L, Uri Saragovi H, Cheung NK.

Clin Cancer Res. 1996 Aug;2(8):1361-7.

2.

Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma.

Mora J, Gerald WL, Cheung NK.

Cancer Lett. 2003 Jul 18;197(1-2):119-24. Review.

PMID:
12880970
3.

A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma.

Ziegler MM, Ishizu H, Nagabuchi E, Takada N, Arya G.

Cancer. 1997 May 1;79(9):1757-66. Review.

PMID:
9128993
4.

Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.

Parodi F, Passoni L, Massimo L, Luksch R, Gambini C, Rossi E, Zuffardi O, Pistoia V, Pezzolo A.

OMICS. 2011 Mar;15(3):113-21. doi: 10.1089/omi.2010.0085. Epub 2011 Feb 14. Review.

PMID:
21319993
5.

Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.

Tomolonis JA, Agarwal S, Shohet JM.

Cell Tissue Res. 2017 Dec 8. doi: 10.1007/s00441-017-2747-0. [Epub ahead of print] Review.

PMID:
29222693
6.

PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs.

Vella S, Conaldi PG, Florio T, Pagano A.

PPAR Res. 2016;2016:3038164. Epub 2016 Oct 5. Review.

Supplemental Content

Support Center